BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 785839)

  • 41. Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures - the importance of hemodynamics in the early postoperative period.
    Procelewska M; Kolcz J; Januszewska K; Mroczek T; Malec E
    Eur J Cardiothorac Surg; 2007 May; 31(5):866-72. PubMed ID: 17329113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
    Girolami A; Scandellari R; Scapin M; Vettore S
    Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
    Pagani A; Zigliani P; Pranzo A; Galante T
    Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coagulation factors of the newborn and his mother.
    Biland L; Duckert F
    Thromb Diath Haemorrh; 1973 Jun; 29(3):644-51. PubMed ID: 4761831
    [No Abstract]   [Full Text] [Related]  

  • 45. Hemostatic defects in massive transfusion: rapid diagnosis and management.
    Reiss RF
    Am J Crit Care; 2000 May; 9(3):158-65; quiz 166-7. PubMed ID: 10800600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis.
    O'Brien JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):116-23. PubMed ID: 4454034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hepatic coagulopathy--principles and therapeutic statements].
    Thaler E; Kleinberger G
    Leber Magen Darm; 1982 Oct; 12(5):193-7. PubMed ID: 7182699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coagulation factor therapy for hemophilia: relation to hepatitis B and to liver function.
    Card RT; Dusevic M; Lukie BE
    Can Med Assoc J; 1982 Jan; 126(1):34-6. PubMed ID: 7059871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunological determination of blood coagulation factors and their importance in the liver diagnosis].
    Breddin K; Lechner K; Brungswig D; Ewe K; Fischer M; Liehr H; Neumayer A; Thaler E
    Z Gastroenterol Verh; 1976; (8):154-62. PubMed ID: 64066
    [No Abstract]   [Full Text] [Related]  

  • 51. Consumption coagulopathy in liver cirrhosis.
    Hörder MH
    Thromb Diath Haemorrh Suppl; 1969; 36():313-8. PubMed ID: 5375546
    [No Abstract]   [Full Text] [Related]  

  • 52. Letter: Prothrombin-complex concentrates in liver disease.
    Lancet; 1975 Jul; 2(7926):188-9. PubMed ID: 49788
    [No Abstract]   [Full Text] [Related]  

  • 53. [The pathogenesis of postoperative abdominal wound dehiscence. Part II: Hemostasiological checks during the course in selected patient groups (author's transl)].
    Schramm W; Schaarschmidt K; Schmidtler F; Schildberg FW
    MMW Munch Med Wochenschr; 1977 May; 119(20):690-4. PubMed ID: 69267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of plasma transfusions on the prothrombin time and clotting factors in liver disease.
    Spector I; Corn M; Ticktin HE
    N Engl J Med; 1966 Nov; 275(19):1032-7. PubMed ID: 5923337
    [No Abstract]   [Full Text] [Related]  

  • 55. A contribution to the pathology of acquired plasma factor XIII deficiency.
    Ballerini G; Guerra S; Rodeghiero F; Castaman G
    Semin Thromb Hemost; 1985 Oct; 11(4):357-61. PubMed ID: 4071061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prothrombin antigen and coagulant activity in patients with liver disease.
    Corrigan JJ; Jeter M; Earnest DL
    JAMA; 1982 Oct; 248(14):1736-9. PubMed ID: 7120594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correction of abnormal coagulation in chronic liver disease by combined use of fresh-frozen plasma and prothrombin complex concentrates.
    Mannucci PM; Franchi F; Dioguardi N
    Lancet; 1976 Sep; 2(7985):542-5. PubMed ID: 60623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The diagnostic value of determining serum-mercaptans in liver disease (author's transl)].
    Brunner G; Scharff P
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1796-800. PubMed ID: 710290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prothrombin complex concentrate: use in controlling the hemorrhagic diathesis of chronic liver disease.
    Bick RL; Schmalhorst WR; Shanbrom E
    Am J Dig Dis; 1975 Aug; 20(8):741-9. PubMed ID: 1080355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Immunological assay for plasma prothrombin--application to coagulation test and liver function test (author's transl)].
    Kitajima K; Okumura M
    Rinsho Ketsueki; 1979 Jun; 20(6):616-22. PubMed ID: 470154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.